1. Home
  2. KSCP vs IGC Comparison

KSCP vs IGC Comparison

Compare KSCP & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knightscope Inc.

KSCP

Knightscope Inc.

HOLD

Current Price

$0.73

Market Cap

35.9M

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

BUY

Current Price

$0.28

Market Cap

32.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
KSCP
IGC
Founded
2013
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.9M
32.0M
IPO Year
2022
2005

Fundamental Metrics

Financial Performance
Metric
KSCP
IGC
Price
$0.73
$0.28
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $12.00
N/A
AVG Volume (30 Days)
★ 856.8K
554.7K
Earning Date
11-12-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.54
59.09
EPS
N/A
★ N/A
Revenue
★ $11,335,000.00
$1,271,000.00
Revenue This Year
$200.57
N/A
Revenue Next Year
$20.44
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 4.91
N/A
52 Week Low
$0.75
$0.24
52 Week High
$7.49
$0.45

Technical Indicators

Market Signals
Indicator
KSCP
IGC
Relative Strength Index (RSI) 17.84 50.59
Support Level N/A $0.27
Resistance Level $2.15 $0.31
Average True Range (ATR) 0.08 0.02
MACD -0.03 -0.00
Stochastic Oscillator 1.53 46.67

Price Performance

Historical Comparison
KSCP
IGC

About KSCP Knightscope Inc.

Knightscope Inc is a security technology company based in Silicon Valley. It designs, develops, manufactures, markets, and supports Autonomous Security Robots (ASRs), autonomous charging stations, the proprietary Knightscope Security Operations Center software user interface, Emergency Communication Devices platform with real-time on-site data collection and analysis and a proprietary interface for both indoor and outdoor usage. In addition, it developed and operates the Knightscope Security Operations Center (KSOC) which allows real-time data access, a service accessible to all its clients.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: